Regeneron Pharmaceuticals, Inc. has a market capitalization of 38934.64, with a return on assets (ROA) of 13.00% and an earnings per share (EPS)Â …
Regeneron Pharmaceuticals, Inc. has a market capitalization of 38934.64, with a return on assets (ROA) of 13.00% and an earnings per share (EPS)Â …
0 Comments